Inventor · disambiguated record
Joost J. Neijssen
Also filed as: NEIJSSEN JOOST · NEIJSSEN JOOST J
19 granted patents·20 pending applications·363 citations·filing 2010–2024
95Inventor score
Top patents by PatentIndex Score
39 records- 0198US11485796B2Inert formatGENMAB AS·Filed 2020·Granted Nov 1, 2022·6 cites·20 claims
- 0297US11866514B2Heterodimeric antibody Fc-containing proteins and methods for production thereofGENMAB AS·Filed 2020·Granted Jan 9, 2024·5 cites·37 claims
- 0397US10597464B2Heterodimeric antibody Fc-containing proteins and methods for production thereofGENMAB AS·Filed 2017·Granted Mar 24, 2020·35 cites·12 claims
- 0497US9150663B2Heterodimeric antibody Fc-containing proteins and methods for production thereofLABRIJN ARAN FRANK·Filed 2011·Granted Oct 6, 2015·119 cites·37 claims
- 0596US10590206B2Inert formatGENMAB AS·Filed 2014·Granted Mar 17, 2020·29 cites·20 claims
- 0695US10344050B2Production of heterodimeric proteinsGENMAB AS·Filed 2012·Granted Jul 9, 2019·40 cites·52 claims
- 0795US9593164B2Bispecific EGFR/c-Met antibodiesJANSSEN BIOTECH INC·Filed 2013·Granted Mar 14, 2017·34 cites·2 claims
- 0894US10407501B2Humanized or chimeric CD3 antibodiesGENMAB AS·Filed 2015·Granted Sep 10, 2019·15 cites·19 claims
- 0993US11492371B2Production of heterodimeric proteinsGENMAB AS·Filed 2019·Granted Nov 8, 2022·9 cites·21 claims
- 1093US9580508B2Bispecific EGFR/c-Met antibodiesJANSSEN BIOTECH INC·Filed 2014·Granted Feb 28, 2017·19 cites·22 claims
- 1192US11613575B2Humanized or chimeric CD3 antibodiesGENMAB AS·Filed 2019·Granted Mar 28, 2023·4 cites·18 claims
- 1292US9657107B2Monoclonal antibodies against c-MetGENMAB AS·Filed 2015·Granted May 23, 2017·9 cites·25 claims
- 1391US10465006B2Humanized or chimeric CD3 antibodiesGENMAB·Filed 2014·Granted Nov 5, 2019·18 cites·19 claims
- 1490US9695242B2Bispecific EGFR/c-Met antibodiesJANSSEN BIOTECH INC·Filed 2016·Granted Jul 4, 2017·8 cites·8 claims
- 1588US9068011B2Monoclonal antibodies against c-MetNEIJSSEN JOOST J·Filed 2011·Granted Jun 30, 2015·12 cites·24 claims
- 1686US2024209117A1Heterodimeric antibody fc-containing proteins and methods for production thereofGENMAB AS·Filed 2023·Application pending·0 cites
- 1784US2024084036A1Monoclonal antibodies against c-metGENMAB AS·Filed 2022·Application pending·0 cites
- 1883US2023374131A1Humanized or chimeric cd3 antibodiesGENMAB AS·Filed 2023·Application pending·0 cites
- 1981US11578141B2Bispecific antibodies against HER2 and CD3GENMAB AS·Filed 2019·Granted Feb 14, 2023·1 cites·11 claims
- 2080US2025066506A1Bispecific antibodies against her2GENMAB AS·Filed 2024·Application pending·0 cites
- 2179US2023322947A1Inert formatGENMAB AS·Filed 2022·Application pending·0 cites
- 2276US12247077B2Bispecific EGFR/c-Met antibodiesJANSSEN BIOTECH INC·Filed 2021·Granted Mar 11, 2025·0 cites·26 claims
- 2376US11512140B2Monoclonal antibodies against c-MetGENMAB AS·Filed 2019·Granted Nov 29, 2022·0 cites·27 claims
- 2475US2020087407A1Bispecific EGFR/C-Met AntibodiesJANSSEN BIOTECH INC·Filed 2019·Application pending·0 cites
- 2573US2023227495A1Production of heterodimeric proteinsGENMAB AS·Filed 2022·Application pending·0 cites
- 2672US2020123255A1Humanized or chimeric cd3 antibodiesGENMAB AS·Filed 2019·Application pending·0 cites
- 2768US2018258173A1Bispecific EGFR/C-Met AntibodiesJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 2867US2021324105A1Bispecific antibodies against her2GENMAB AS·Filed 2021·Application pending·0 cites
- 2962US2017313782A1Monoclonal antibodies against c-metGENMAB AS·Filed 2017·Application pending·0 cites
- 3062US2017320962A1Monoclonal antibodies against c-metGENMAB AS·Filed 2017·Application pending·0 cites
- 3161US2017275367A1Bispecific EGFR/C-Met AntibodiesJANSSEN BIOTECH INC·Filed 2017·Application pending·0 cites
- 3257US11932693B2Monoclonal antibodies directed against programmed death-1 protein and their use in medicineBioNTech SE·Filed 2023·Granted Mar 19, 2024·0 cites·30 claims
- 3355US2025002600A1Multispecific binding agents against pd-l1 and cd137 in combination therapyGENMAB AS·Filed 2022·Application pending·0 cites
- 3455US2016046727A1Heterodimeric antibody fc-containing proteins and methods for production thereofGENMAB AS·Filed 2015·Application pending·0 cites
- 3553US2017369590A1Bispecific antibodies against her2GENMAB AS·Filed 2017·Application pending·0 cites
- 3653US2017369594A1Bispecific antibodies against her2 and cd3GENMAB AS·Filed 2017·Application pending·0 cites
- 3750US2014170149A1Bispecific antibodies against her2 and cd3NEIJSSEN JOOST J·Filed 2012·Application pending·0 cites
- 3841US2014170148A1Bispecific antibodies against her2DE GOEIJ BART·Filed 2012·Application pending·0 cites
- 3934US2012020952A1Methods for producing mixtures of antibodiesPARREN PAUL·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joost J. Neijssen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →